Published in Radiol Bras on March 23, 2015
Pitfalls and artifacts in the interpretation of oncologic PET/CT of the chest. Radiol Bras (2017) 0.75
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med (2006) 3.51
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med (2006) 3.15
Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med (2007) 3.08
Fluorine-18: a new isotope for bone scanning. J Nucl Med (1962) 2.07
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2009) 1.87
SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med (2010) 1.63
18F-Fluoride positron emission tomography and positron emission tomography/computed tomography. Semin Nucl Med (2007) 1.61
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol (1999) 1.58
Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med (2004) 1.51
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med (2001) 1.47
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med (2006) 1.39
F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res (2003) 1.26
Weight-based, low-dose pediatric whole-body PET/CT protocols. J Nucl Med (2009) 1.24
Comparison of different quantitative approaches to 18F-fluoride PET scans. J Nucl Med (2004) 1.19
CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging (2002) 1.13
Whole body skeletal imaging with [18F]fluoride ion and PET. J Comput Assist Tomogr (1993) 1.07
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases. J Nucl Med (2010) 1.04
18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin). EJNMMI Res (2011) 1.03
Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: phantom study. Radiology (2007) 1.00
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases. Clin Nucl Med (2013) 0.94
Global shortage of medical isotopes threatens nuclear medicine services. BMJ (2008) 0.85
Clinical evaluation of the effect of attenuation correction technique on 18F-fluoride PET images. Ann Nucl Med (2007) 0.85
Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT. Nucl Med Commun (2012) 0.81
18F-fluoride PET/CT for bone scanning. Role of attenuation correction. Nuklearmedizin (2012) 0.80
Time course of bone metabolism at the residual ridge beneath dentures observed using ¹⁸F-fluoride positron emission computerized-tomography/computed tomography (PET/CT). Ann Nucl Med (2012) 0.79
Prevalence of clinically significant extraosseous findings on unenhanced CT portions of ¹⁸F-fluoride PET/CT bone scans. ScientificWorldJournal (2012) 0.77